Media Center
Press Releases

Press Releases

12 May 15
Muscular Dystrophy Treatment Pipeline Offers Hope for Improved Life Expectancy, says GBI Research

The highly diverse and innovative pipeline for Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD) treatment has the potential to produce therapies that will help repair the mutated gene, halt muscle degeneration, and improve patients’ life expectancy.

Read post
07 May 15
Asia-Pacific Market for Psoriasis Treatment Almost Doubling to $1.2 Billion by 2021

The Asia-Pacific (APAC) treatment market for psoriasis will almost double in value, from $690 million in 2014 to $1.2 billion by 2021, representing a Compound Annual Growth Rate (CAGR) of 8.4%, according to business intelligence provider GBI Research.

Read post
29 Apr 15
UK Will Remain Europe’s Asthma Hotspot with 9.1 Million Sufferers by 2020, says GBI Research

The UK will continue to be the asthma capital of Europe, as the country’s prevalent population will increase from 7.6 million in 2013 to 9.1 million by 2020, with a substantially higher prevalence rate than that found in France, Germany, Italy and Spain.

Read post
21 Apr 15
Lifestyle is Key Contributor to Heart Disease as Leading Cause of Male Death, says GBI Research

Affecting an estimated 8.8 million men in the US, Coronary Heart Disease (CHD) exerts an extremely high burden on male health, with testosterone, cholesterol and lifestyle contributing to poorer outcomes for these patients.

Read post
07 Apr 15
Diverse Pipeline Could Transform Liver Cancer Treatment within Next Decade

Liver cancer treatment has the potential to undergo an impressive transformation over the next 10 years, with a diverse pipeline of 218 products targeting several major needs that are unmet by the current market.

Read post